← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2001Last known activity
Mar 31, 2025
Timeline
1940s
- Jun 1, 1947
Dr. Falk Pharma GmbH— Founded
Drugs by trial phase (15 distinct, 47 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
- Cholangitis
- Cholangitis, Sclerosing
- Cholecystolithiasis
- Cholelithiasis
- Colitis
- Colitis, Collagenous
- Colitis, Lymphocytic
- Colitis, Microscopic
- Colitis, Ulcerative
- Crohn Disease
- Diarrhea
- Diverticular Diseases
- Diverticulitis
- Diverticulosis, Colonic
- Diverticulum
- Dysentery
- Eosinophilic Esophagitis
- Esophagitis
- Esophagitis, Peptic
- Fibrosis
- Gallstones
- Gastroesophageal Reflux
- Graft vs Host Disease
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis, Autoimmune
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Proctitis
- Recurrence
- Ulcer
Recent trials (50)
- NCT06886360Lead sponsorPhase 3Mar 31, 2025
- NCT07298343Lead sponsorPhase 2Jun 10, 2024
- NCT05488405Lead sponsorPhase 2Nov 30, 2022
- NCT05621811Lead sponsorPhase 2Nov 30, 2022
- NCT05305599Lead sponsorPhase 2Apr 19, 2022
- NCT06596252Lead sponsorPhase 3May 21, 2021
- NCT05083390Lead sponsorPhase 2Jul 8, 2019
- NCT03844932CollaboratorPhase 2Jan 24, 2019
- NCT03872921Lead sponsorPhase 3Feb 8, 2018
- NCT02493335Lead sponsorPhase 3Jan 15, 2016
- NCT02493335Study directorPhase 3Jan 15, 2016
- NCT02434029Study directorPhase 3Nov 11, 2015
- NCT02434029Lead sponsorPhase 3Nov 11, 2015
- NCT02550418Lead sponsorPhase 2Oct 1, 2015
- NCT02280629Lead sponsorPhase 3Oct 1, 2014
Details
- Founded
- Freiburg, DE Jun 1, 1947
- Last known activity
- Mar 31, 2025